FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2318887310> ?p ?o ?g. }

• W2318887310 endingPage "1510" @default.
• W2318887310 startingPage "1505" @default.
• W2318887310 abstract "This safety lead-in study examined the pharmacokinetic and adverse event profile of combining enzastaurin with paclitaxel plus carboplatin as first-line therapy for the treatment of advanced-stage ovarian cancer and primary peritoneal carcinoma. The specific objectives of this study were to assess safety and tolerability after 2 cycles of treatment, to determine if enzastaurin alters paclitaxel and carboplatin pharmacokinetics, and to determine if enzastaurin pharmacokinetics is affected by paclitaxel and carboplatin.After debulking surgery, patients with previously untreated epithelial ovarian or primary peritoneal carcinoma received sequential paclitaxel (175 mg/m) and carboplatin (area under the curve, 5 mg x min/mL) on day 1 every 3 weeks for 6 cycles. Patients ingested an oral loading dose of 1125 mg enzastaurin on day 4 of cycle 1, followed by oral 500-mg enzastaurin daily until the end of therapy. Adverse events were graded according to the Common Terminology Criteria for Adverse Events v3.0.There were 5 serious adverse events in 4 of 11 patients: soft tissue injury, wound infection, intestinal fistula, clostridial infection, and anemia. Coadministration with enzastaurin did not significantly alter paclitaxel and carboplatin pharmacokinetics (area under the curve ratio of treatment comparison asymptotically equal to 1.05 and 1.06, respectively). Enzastaurin exposures were unchanged (Cav,ss ratio of treatment comparison asymptotically equal to 0.95 for average steady-state total analyte concentrations of enzastaurin and its metabolite).Adding enzastaurin to paclitaxel plus carboplatin chemotherapy is feasible for advanced ovarian cancer after radical cytoreduction. Enzastaurin did not alter paclitaxel or carboplatin pharmacokinetics, and enzastaurin exposures were not significantly changed by carboplatin and paclitaxel." @default.
• W2318887310 created "2016-06-24" @default.
• W2318887310 creator A5002555374 @default.
• W2318887310 creator A5012399052 @default.
• W2318887310 creator A5012662423 @default.
• W2318887310 creator A5017676377 @default.
• W2318887310 creator A5022619396 @default.
• W2318887310 creator A5023783658 @default.
• W2318887310 creator A5029099261 @default.
• W2318887310 creator A5058535647 @default.
• W2318887310 creator A5070675863 @default.
• W2318887310 date "2009-11-01" @default.
• W2318887310 modified "2023-10-16" @default.
• W2318887310 title "Carboplatin and Paclitaxel in Combination With Oral Enzastaurin in Advanced Ovarian or Primary Peritoneal Cancer: Results From a Safety Lead-in Study" @default.
• W2318887310 cites W1550111394 @default.
• W2318887310 cites W1974415860 @default.
• W2318887310 cites W1997539987 @default.
• W2318887310 cites W2024485560 @default.
• W2318887310 cites W2028946225 @default.
• W2318887310 cites W2072304154 @default.
• W2318887310 cites W2098987087 @default.
• W2318887310 cites W2120601121 @default.
• W2318887310 cites W2126372596 @default.
• W2318887310 cites W2136654252 @default.
• W2318887310 cites W2141652044 @default.
• W2318887310 cites W2143102005 @default.
• W2318887310 cites W2156804105 @default.
• W2318887310 cites W2161806452 @default.
• W2318887310 cites W2169505101 @default.
• W2318887310 cites W2172187886 @default.
• W2318887310 cites W2242155271 @default.
• W2318887310 doi "https://doi.org/10.1111/igc.0b013e3181bda1a7" @default.
• W2318887310 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19955926" @default.
• W2318887310 hasPublicationYear "2009" @default.
• W2318887310 type Work @default.
• W2318887310 sameAs 2318887310 @default.
• W2318887310 citedByCount "8" @default.
• W2318887310 countsByYear W23188873102012 @default.
• W2318887310 countsByYear W23188873102013 @default.
• W2318887310 countsByYear W23188873102014 @default.
• W2318887310 countsByYear W23188873102015 @default.
• W2318887310 crossrefType "journal-article" @default.
• W2318887310 hasAuthorship W2318887310A5002555374 @default.
• W2318887310 hasAuthorship W2318887310A5012399052 @default.
• W2318887310 hasAuthorship W2318887310A5012662423 @default.
• W2318887310 hasAuthorship W2318887310A5017676377 @default.
• W2318887310 hasAuthorship W2318887310A5022619396 @default.
• W2318887310 hasAuthorship W2318887310A5023783658 @default.
• W2318887310 hasAuthorship W2318887310A5029099261 @default.
• W2318887310 hasAuthorship W2318887310A5058535647 @default.
• W2318887310 hasAuthorship W2318887310A5070675863 @default.
• W2318887310 hasConcept C112705442 @default.
• W2318887310 hasConcept C121608353 @default.
• W2318887310 hasConcept C126322002 @default.
• W2318887310 hasConcept C126894567 @default.
• W2318887310 hasConcept C143998085 @default.
• W2318887310 hasConcept C197934379 @default.
• W2318887310 hasConcept C2776694085 @default.
• W2318887310 hasConcept C2777292972 @default.
• W2318887310 hasConcept C2777793932 @default.
• W2318887310 hasConcept C2778239845 @default.
• W2318887310 hasConcept C2778375690 @default.
• W2318887310 hasConcept C2780427987 @default.
• W2318887310 hasConcept C2781451048 @default.
• W2318887310 hasConcept C71924100 @default.
• W2318887310 hasConcept C98274493 @default.
• W2318887310 hasConceptScore W2318887310C112705442 @default.
• W2318887310 hasConceptScore W2318887310C121608353 @default.
• W2318887310 hasConceptScore W2318887310C126322002 @default.
• W2318887310 hasConceptScore W2318887310C126894567 @default.
• W2318887310 hasConceptScore W2318887310C143998085 @default.
• W2318887310 hasConceptScore W2318887310C197934379 @default.
• W2318887310 hasConceptScore W2318887310C2776694085 @default.
• W2318887310 hasConceptScore W2318887310C2777292972 @default.
• W2318887310 hasConceptScore W2318887310C2777793932 @default.
• W2318887310 hasConceptScore W2318887310C2778239845 @default.
• W2318887310 hasConceptScore W2318887310C2778375690 @default.
• W2318887310 hasConceptScore W2318887310C2780427987 @default.
• W2318887310 hasConceptScore W2318887310C2781451048 @default.
• W2318887310 hasConceptScore W2318887310C71924100 @default.
• W2318887310 hasConceptScore W2318887310C98274493 @default.
• W2318887310 hasIssue "9" @default.
• W2318887310 hasLocation W23188873101 @default.
• W2318887310 hasLocation W23188873102 @default.
• W2318887310 hasOpenAccess W2318887310 @default.
• W2318887310 hasPrimaryLocation W23188873101 @default.
• W2318887310 hasRelatedWork W2034009362 @default.
• W2318887310 hasRelatedWork W2053778437 @default.
• W2318887310 hasRelatedWork W2072767112 @default.
• W2318887310 hasRelatedWork W2105623825 @default.
• W2318887310 hasRelatedWork W2157919202 @default.
• W2318887310 hasRelatedWork W2311734504 @default.
• W2318887310 hasRelatedWork W2320097775 @default.
• W2318887310 hasRelatedWork W2410995755 @default.
• W2318887310 hasRelatedWork W2417634857 @default.
• W2318887310 hasRelatedWork W2968124559 @default.
• W2318887310 hasVolume "19" @default.
• W2318887310 isParatext "false" @default.

• next